Avanos Medical Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -20.9% | +3.6% | +6.0% | -16.5% | -1.8% | -7.0% | -4.1% | +11.4% | -5.3% | -31.8% | -7.0% | |
| – | -1.3% | -12.2% | +95.6% | -38.5% | -24.5% | -13.2% | -8.5% | +46.0% | -22.0% | -19.2% | -9.7% | |
| – | -13.1% | -12.2% | +93.2% | +75.0% | -46.6% | -45.7% | +6.3% | +7.8% | -31.3% | +22.8% | -16.6% | |
| – | -13.1% | -12.2% | +93.2% | +75.0% | -46.6% | -45.7% | +6.3% | +7.8% | -31.3% | +22.8% | -16.6% | |
| – | -3.9% | -15.4% | +6.8% | -25.9% | +8.8% | +2.5% | -21.9% | +28.0% | -14.9% | -7.0% | -21.8% | |
| – | +7.1% | -10.1% | -66.6% | +33.3% | +20.2% | +15.8% | -5.7% | -16.9% | +23.4% | -15.0% | +6.6% | |
| – | +0.6% | -6.7% | -57.9% | +40.2% | +19.7% | -5.0% | -4.1% | -2.5% | – | – | – | |
| – | -33.7% | +8.9% | -25.7% | +2.5% | +2.2% | +0.2% | -0.1% | -5.2% | +4.7% | -42.8% | -13.3% | |
| – | -23.7% | +105.6% | -12.3% | +13.0% | +9.6% | -14.4% | -10.5% | +65.9% | +2.3% | -53.1% | +4.9% | |
| – | -8.8% | +2.6% | +1.2% | -45.3% | -0.3% | -22.1% | -20.0% | +48.9% | -8.0% | -28.6% | -9.3% | |
| – | -11.5% | +2.9% | +20.2% | -32.2% | -19.6% | -21.7% | -16.3% | +37.2% | +22.8% | -29.3% | -0.4% | |
| – | +14,723.1% | +0.2% | -93.1% | – | – | +5.4% | -5.2% | +23.8% | +17.6% | -5.1% | -9.4% | |
| – | -3.3% | +6.1% | -1.1% | -0.8% | -51.1% | -18.6% | -16.6% | +20.4% | -17.1% | -3.6% | +2.2% | |
| – | -8.6% | +0.2% | -6.5% | -54.2% | +0.2% | -27.4% | -27.8% | +74.1% | -29.6% | -21.4% | -27.9% | |
| – | -29.2% | +4.5% | +10.2% | +6.7% | -2.5% | -0.7% | +1.1% | +1.6% | -4.3% | -33.0% | -6.1% | |
| – | -5,839.7% | – | – | – | – | – | – | – | – | – | – | |
| – | +0.1% | +0.9% | -0.4% | +0.9% | +0.8% | +0.4% | +1.7% | -2.7% | -1.5% | -1.3% | +0.9% |
Data as of: July 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.